Answers are grounded in this paper and cite their sources.
Observational analysis found significant anti-diabetic activity in azadirachta indica, suggesting its potential for managing type 2 diabetes.
This research paper explains the nature of pharmacogenetics and anti-diabatic roles of Azadirachta indica (neem) leaves. Pharmacogenetic serials of phytochemical checks (microscopy, physicochemical tests ash test; extractive values) were performed on the shade-dried leaves. Extracts were made methanolically and extraction was done using water. The methods used in test were antioxidant (DPPH, ABTS), inhibition of α-amylase, inhibition of α-glucosidase and in vitro experiments. The in vivo anti-diabetic efficiency was studied on the high-fat diet/ streptozotocin (HFD/STZ) induced Type 2 diabetic rat by administration of 100, 200, and 400 mg/kg of 30 days. Blood gligatorid levels, glucose intolerance, lipid peroxidation, and antioxidant status and histopathology of pancreatic tissues were assessed and metformin was performed as a positive control. HPLC/HPTLC demonstrated rutin, quercetin and ellagic acid using methanolic extract. Extrates showed good ability of antioxidant and enzyme inhibition; the 400 mg/kg dose notably corrected glycemia, reversed lipid and antioxidants levels. The histology revealed the recovery of pancreatic structure.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: